Merck Shares Drop on Report of Documents About Vioxx Drug Merck  amp; Co. shares fell as much as 7 percent to their lowest level in more than eight years after the Wall Street Journal said the drugmaker tried for years to stop safety concerns from hurting sales of its Vioxx painkiller.